Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia

Schizophrenia Research

Volumn 151, Issue 1-3, 2013, Pages 61-69

  Moritz, Steffen ^a   Veckenstedt, Ruth ^a   Bohn, Francesca ^a   Hottenrott, Birgit ^a   Scheu, Florian ^b   Randjbar, Sarah ^a   Aghotor, Julia ^b   Köther, Ulf ^a   Woodward, Todd S ^c,d   Treszl, András ^a   Andreou, Christina ^a   Pfueller, Ute ^b,e   Roesch Ely, Daniela ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BC Mental Health and Addictions Research Institute   (Canada)

^e Klinikum Karlsbad Langensteinbach   (Germany)

Author keywords

Cognitive biases; Jumping to conclusions; Metacognitive Training; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DECISION MAKING; DELUSION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METACOGNITIVE TRAINING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC SYMPTOM RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM;

COGNITIVE BIASES; JUMPING TO CONCLUSIONS; METACOGNITIVE TRAINING; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; AWARENESS; COGNITIVE THERAPY; DELUSIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 84889089048     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.10.007     Document Type: Article

References (69)

1. Aghotor J., Pfueller U., Moritz S., Weisbrod M., Roesch-Ely D. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J. Behav. Ther. Exp. Psychiatry 2010, 41:207-211.
2. Bell V., Halligan P.W., Ellis H.D. Explaining delusions: a cognitive perspective. Trends Cogn. Sci. 2006, 10:219-226.
3. Borm G.F., Fransen J., Lemmens W.A. A simple sample size formula for analysis of covariance in randomized clinical trials. J. Clin. Epidemiol. 2007, 60:1234-1238.
4. Brickenkamp R. Test d2 Aufmerksamkeits-Belastungs-Test 1978, Hogrefe, Göttingen.
5. Carpenter J.R., Kenward M.G. Missing Data in Randomised Controlled Trials - A Practical Guide 2008, National Institute for Health Research, Birmingham, (Publication RM03/JH17/MK).
6. Combs D.R., Adams S.D., Penn D.L., Roberts D., Tiegreen J., Stem P. Social Cognition and Interaction Training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr. Res. 2007, 91:112-116.
7. Drake R., Haddock G., Tarrier N., Bentall R., Lewis S. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr. Res. 2007, 89:119-122.
8. Eisen J.L., Phillips K.A., Baer L., Beer D.A., Atala K.D., Rasmussen S.A. The Brown Assessment of Beliefs Scale: reliability and validity. Am. J. Psychiatr. 1998, 155:102-108.
9. Erdfelder E., Faul F., Buchner A. GPOWER: a general power analysis program. Behav. Res. Methods Instrum. Comput. 1996, 28:1-11.
10. Favrod J., Maire A., Bardy S., Pernier S., Bonsack C. Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J. Adv. Nurs. 2011, 67:401-407.
11. Favrod J.S., Rexhaj S., Bardy S., Ferrari P., Hayoz C., Moritz S., Conus P., Bonsack C. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Eur. Psychiatry 2013, (in press).
12. Fisher P., Wells A. Metacognitive Therapy 2009, Routledge, East Sussex.
13. Freeman D. Suspicious minds: the psychology of persecutory delusions. Clin. Psychol. Rev. 2007, 27:425-457.
14. Garety P.A., Freeman D. Cognitive approaches to delusions: a critical review of theories and evidence. Br. J. Clin. Psychol. 1999, 38:113-154.
15. Garety P.A., Fowler D.G., Freeman D., Bebbington P., Dunn G., Kuipers E. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br. J. Psychiatry 2008, 192:412-423.
16. Haddock G., McCarron J., Tarrier N., Faragher E.B. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol. Med. 1999, 29:879-889.
17. Hollon S.D., Wampold B.E. Are randomized controlled trials relevant to clinical practice?. Can. J Psychiatry Rev. Can. Psychiatr. 2009, 54:637-639.
18. Karow A., Pajonk F.G. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr. Opin. Psychiatry 2006, 19:637-641.
19. Kay S.R., Opler L.A., Lindenmayer J.P. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br. J. Psychiatry 1989, 155(Suppl. 7):59-67.
20. Kendall T. The rise and fall of the atypical antipsychotics. Br. J. Psychiatry 2011, 199:266-268.
21. Kenward M.G., Roger J.H. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997, 53:983-997.
22. Kinnear P.R., Gray C.D. SPSS 16 - Made Simple 2009, Taylor & Francis, London.
23. Kumar D., Zia Ul Haq M., Dubey I., Dotiwala K., Siddiqui S.V., Abhishek P. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur. J. Psychother. Couns. 2010, 12:149-158.
24. Kurtz M.M. Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence?. Clin. Psychol. Rev. 2011, 31:663-672.
25. Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am. J. Psychiatr. 2003, 160:1209-1222.
26. Leucht S., Arbter D., Engel R.R., Kissling W., Davis J.M. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol. Psychiatry 2009, 14:429-447.
27. Liang K.-Y., Zeger S.L. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Indian J. Stat. Series B 2000, 62:134-148.
28. Lincoln T.M., Lüllmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 2007, 33:1324-1342.
29. Lincoln T.M., Suttner C., Nestoriuc Y. Wirksamkeit kognitiver Interventionen in der Reduktion schizophrener Symptomatik. Eine Meta-Analyse. Psychol. Rundsch. 2008, 59:217-232.
30. Liu G.H.F., Lu K.F., Mogg R., Mallick M., Mehrotra D.V. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?. Stat. Med. 2009, 28:2509-2530.
31. Marker K. COGPACK Manual Version 5.9 2003, Marker Software, Ladenburg.
32. McEvoy J.P. The costs of schizophrenia. J. Clin. Psychiatry 2007, 68(Suppl. 14):4-7.
33. Menon M., Mizrahi R., Kapur S. The association between delusions and 'jumping to conclusions': cross sectional and longitudinal analyses. Schizophr. Res. 2006, 81:21-21.
34. Moritz S., Woodward T.S. Jumping to conclusions in delusional and non-delusional schizophrenic patients. Br. J. Clin. Psychol. 2005, 44:193-207.
35. Moritz S., Woodward T.S. Metacognitive training for schizophrenia patients (MCT): a pilot study on feasibility, treatment adherence, and subjective efficacy. German J. Psychiatry 2007, 10:69-78.
36. Moritz S., Woodward T.S. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr. Opin. Psychiatry 2007, 20:619-625.
37. Moritz S., Woodward T.S., Burlon M. Metacognitive skill training for patients with psychosis (MCT). Manual 2005, Van Ham Campus, Hamburg.
38. Moritz S., Woodward T.S., Lambert M. Under what circumstances do patients with schizophrenia jump to conclusions? A liberal acceptance account. Br. J. Clin. Psychol. 2007, 46:127-137.
39. Moritz S., Veckenstedt R., Hottenrott B., Woodward T.S., Randjbar S., Lincoln T.M. Different sides of the same coin? Intercorrelations of cognitive biases in schizophrenia. Cogn. Neuropsychiatr. 2010, 15:406-421.
40. Moritz S., Vitzthum F., Randjbar S., Veckenstedt R., Woodward T.S. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr. Opin. Psychiatry 2010, 23:561-569.
41. Moritz S., Woodward T.S. Metacognitive training for psychosis (MCT). Manual 2010, Metacognition Study Group, VanHam Campus, Hamburg. 4th edition.
42. Moritz S., Kerstan A., Veckenstedt R., Randjbar S., Vitzthum F., Schmidt C., Heise M., Woodward T.S. Further evidence for the efficacy of a metacognitive group training in psychosis. Behav. Res. Ther. 2011, 49:151-157.
43. Moritz S., Veckenstedt R., Randjbar S., Vitzthum F., Woodward T.S. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol. Med. 2011, 41:1823-1832.
44. Moritz S., Andreou C., Klingberg S., Thoering T., Peters M.J. Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?. Neuropharmacology 2013, 72:179-186.
45. Mortimer A.M. Symptom rating scales and outcome in schizophrenia. Br. J. Psychiatry 2007, 191:S7-S14.
46. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53:31-40.
47. Peters E., Garety P. Cognitive functioning in delusions: a longitudinal analysis. Behav. Res. Ther. 2006, 44:481-514.
48. Reavley N.J., Jorm A.F. Young people's stigmatizing attitudes towards people with mental disorders: findings from an Australian national survey. Aust. N. Z. J. Psychiatry 2011, 45:1033-1039.
49. Reitan R.M. Trail Making Test. Manual for Administration and Scoring 1992, Reitan Neuropsychology Laboratory, South Tucson, Arizona.
50. Roberts D.L., Penn D.L. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res. 2009, 166:141-147.
51. Rosenberg M. Society and the Adolescent Self Image 1965, Princeton University Press, Princeton, NJ.
52. Ross K., Freeman D., Dunn G., Garety P. A randomized experimental investigation of reasoning training for people with delusions. Schizophr. Bull. 2011, 37:324-333.
53. Roth M., Decker O., Herzberg P.Y., Brähler E. Dimensionality and norms of the Rosenberg Self-esteem Scale in a German general population sample. Eur. J. Psychol. Assess. 2008, 24:190-197.
54. Saarni S.I., Viertio S., Perala J., Koskinen S., Lonnqvist J., Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 2010, 197:386-394.
55. Santor D.A., Ascher-Svanum H., Lindenmayer J.P., Obenchain R.L. Item response analysis of the Positive and Negative Syndrome Scale. BMC Psychiatry 2007, 7:66.
56. Schneider S.D., Jelinek L., Lincoln T.M., Moritz S. What happened to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment. Psychiatry Res. 2011, 188:13-17.
57. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
58. So S.H., Garety P.A., Peters E.R., Kapur S. Change in delusional dimensional dimensions, reasoning biases and emotions in the first eight weeks of antipsychotic treatment. Schizophr. Res. 2012, 136(Suppl. 1):S375.
59. Speechley W.J., Whitman J.C., Woodward T.S. The contribution of hypersalience to the "jumping to conclusions" bias associated with delusions in schizophrenia. J. Psychiatry Neurosci. 2010, 35:7-17.
60. Suzuki T. Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review. Psychopharmacol. Bull. 2011, 44:18-31.
61. van der Gaag M. A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophr. Bull. 2006, 32(Suppl. 1):113-122.
62. Vickers A.J., Altman D.G. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001, 323:1123-1124.
63. Waller H., Freeman D., Jolley S., Dunn G., Garety P. Targeting reasoning biases in delusions: a pilot study of the Maudsley Review Training Programme for individuals with persistent, high conviction delusions. J. Behav. Ther. Exp. Psychiatry 2011, 42:414-421.
64. Wilson B.A., Cockburn J., Baddeley A.D. The Rivermead Behavioural Memory Test 1985, Thames Valley Test Company, Bury St Edmunds.
65. Wilson B., Cockburn J., Baddeley A., Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J. Clin. Exp. Neuropsychol. 1989, 11:855-870.
66. Woodward T.S., Mizrahi R., Menon M., Christensen B.K. Correspondences between theory of mind, jumping to conclusions, neuropsychological measures and the symptoms of schizophrenia. Psychiatry Res. 2009, 170:119-123.
67. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 2008, 34:523-537.
68. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatr. 2011, 168:472-485.
69. Zimmermann G., Favrod J., Trieu V.H., Pomini V. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr. Res. 2005, 77:1-9.